Neuropsychopharmacology
- Genome-wide association studies of coffee intake in UK/US participants of European ancestry uncover cohort-specific genetic associations2 years ago
- Cracking the chicken and egg problem of schizophrenia and substance use: Genetic interplay between schizophrenia, cannabis use disorder, and tobacco smoking2 years ago
- Smoking-informed methylation and expression QTLs in human brain and colocalization with smoking-associated genetic loci2 years ago
- Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam2 years ago
- Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks2 years ago
- Dorsal raphe to basolateral amygdala corticotropin-releasing factor circuit regulates cocaine-memory reconsolidation2 years ago
- Isradipine augmentation of virtual reality cue exposure therapy for tobacco craving: a triple-blind randomized controlled trial2 years ago
Journal of Psychopharmacology
- Effectiveness of vortioxetine in patients with major depressive disorder and co-morbid generalized anxiety disorder in routine clinical practice: A subgroup analysis of the RELIEVE study3 years ago
- Body mass index (BMI) does not predict responses to psilocybin3 years ago
- Pharmacological characterization of 5-iodo-A-85380, a β2-selective nicotinic receptor agonist, in mice3 years ago
- Association between quetiapine use and self-harm outcomes among people with recorded personality disorder in UK primary care: A self-controlled case series analysis3 years ago
- Belief changes associated with psychedelic use3 years ago
- Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes3 years ago
- The influence of stimulus onset asynchrony, task order, sex and hormonal contraception on prepulse inhibition and prepulse facilitation: Methodological considerations for drug and imaging research3 years ago
European Neuropsychopharmacology
- A shared decision journey to bridge the gap between treatment recommendation and low adherence?3 years ago
- Neuroimaging revealed long-lasting glucose metabolism changes to morphine withdrawal in rats pretreated with the cannabinoid agonist CP-55,940 during periadolescence3 years ago
- Treating major depressive disorder with mixed features3 years ago
- New biomarkers in mood disorders: Insights from immunopsychiatry and neuroimaging3 years ago
- In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior3 years ago
- Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes3 years ago
- Initial response to the COVID-19 pandemic on real-life well-being, social contact and roaming behavior in patients with schizophrenia, major depression and healthy controls: A longitudinal ecological momentary assessment study3 years ago